article thumbnail

CVS scheme diverted millions from underserved population, NY AG says

MedCity News

Attorney General Letitia James accused CVS of a scheme starting in 2017 to prevent New York safety net hospitals from using the company of their choice to obtain federal drug subsidies on prescriptions filled at CVS through the 340B program.

article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. This could cost taxpayers billions over the year. 2 by the PBM Accountability Project.

Insurance 240
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said.

FDA 234
article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence. Photo: Bulat Silvia, Getty Images

article thumbnail

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

prescription drug sales signals that big pharma will do anything to avoid hurting profits. For several years, Humira was the best-selling prescription drug in the world.1 In AbbVie’s’ own words, “The changes made by the 2017 tax law altered U.S. taxation on foreign earnings for U.S.

Sales 269
article thumbnail

Insulin prices demonstrate pharma’s greed

World of DTC Marketing

According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. In the five-yearperiodfrom2016to2020, pharmaceutical companies raised the prices of branded prescription drugs by 36%—almost four times the rate of inflation during that period.

article thumbnail

AbbVie sucks

World of DTC Marketing

The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023.